Pharmaceuticals & Biotechnology

For companies in the pharmaceutical and biotech space, business valuation involves more than revenue and assets—it’s about understanding intellectual property, research milestones, regulatory approval stages, and the future potential of life-changing innovation. At Strong Tower Valuations, we deliver certified valuations designed to meet the complexity of this high-stakes, highly regulated industry.

Why Accurate Valuation Matters in Life Sciences

Whether you’re raising capital, preparing for an acquisition, issuing employee stock, or planning succession, a well-supported valuation builds confidence with investors, regulators, attorneys, and stakeholders. We provide detailed, defensible valuations that meet IRS, SBA, and industry standards while aligning with your company’s stage of development and strategic goals.

Key Valuation Factors in Pharma & Biotech

• Pipeline development and R&D progress
• Stage of clinical trials and regulatory milestones (e.g., IND, NDA, FDA approval)
• Market exclusivity and patent protection
• IP portfolio and licensing agreements
• Partnering deals and royalty structures
• Cash burn rate and financing history
• Revenue projections and commercial potential

When to Seek a Professional Valuation

• Fundraising or venture capital negotiations
• M&A, licensing, or joint venture planning
• Stock option pricing (409A)
• Estate or gift tax planning
• Exit planning or shareholder transitions

Request a Consultation to ensure your life sciences company is valued with precision, clarity, and compliance.

Who We Serve

• Early-stage biotech and pharmaceutical startups
• Clinical-stage drug developers
• Medical research organizations
• Pharma and biologic manufacturers
• Life science venture firms and legal teams

Why Life Sciences Firms Choose Strong Tower Valuations

• Certified appraisers with deep industry knowledge
• Defensible, audit-ready reports trusted by attorneys, investors, and the IRS
• Customized methodologies based on your stage of development and risk profile
• Clear, strategic insight for complex decision-making and growth planning

Clarity and Confidence in a Regulated Industry

Valuing a pharmaceutical or biotech company requires more than formulas—it demands a deep understanding of innovation timelines, scientific uncertainty, and commercial potential. Strong Tower Valuations delivers certified reports that meet regulatory standards while helping founders, investors, and legal teams move forward with confidence.

Request a Consultation and find out how we support life sciences companies at every stage of growth and transition.